Advertisement

Topics

DACOGEN Company Profile

15:19 EDT 23rd June 2018 | BioPortfolio

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System (IPSS) groups.

Location

Bloomington
Minnesota
55437
United States of America

Contact

Email: techsupport@dacogen.com.


News Articles [0 Results]

None

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Dacogen [Eisai Inc.]

These highlights do not include all the information needed to use Dacogen safely and effectively. See full prescribing information for Dacogen. DACOGEN (decitabine) for INJECTIONInitial U.S. Approval:...

PubMed Articles [0 Results]

None

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

An Efficacy and Safety Study of Decitabine (DACOGEN) Plus JNJ-56022473 (Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

The primary objective of study Part A is to assess the safety of JNJ-56022473 (formerly CSL362) monotherapy and confirm the recommended Phase 2 dose (RP2D) in participants with acute myel...

Efficacy and Safety of Dacogen

The objective of this study is to evaluate the efficacy and safety data of the patients treated with decitabine (Dacogen) intravenous injection

Trial of Decitabine in Patients With Acute Myeloid Leukemia

The purpose of this study is to compare the results in older patients who have newly diagnosed or secondary acute myeloid leukemia (AML) and who are to either receive decitabine or patient...

Phase 3 Study of ASTX727 vs IV Decitabine in MDS and CMML

Multicenter, randomized, open-label, crossover PK study of ASTX727 versus IV decitabine. Adult subjects who are candidates to receive IV decitabine will be randomized 1:1 to receive the AS...

A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia

The purpose of this study is to examine the safety and efficacy of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukemia (A...

Companies [1 Associated Companies listed on BioPortfolio]

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes ...

More Information about "DACOGEN" on BioPortfolio

We have published hundreds of DACOGEN news stories on BioPortfolio along with dozens of DACOGEN Clinical Trials and PubMed Articles about DACOGEN for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DACOGEN Companies in our database. You can also find out about relevant DACOGEN Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...


Corporate Database Quicklinks



Searches Linking to this Company Record